Research map: Mechanism-Informed Drug Repurposing in MINOCA: Therapeutic Rationale and Trial Framework for Empagliflozin and Colchicine

Back to the article

Papers in this map

  1. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction · Jean‐Claude Tardif · 2019 · 3144 citations · Cited by this paper
  2. Anatomy-Specific Association of Circulating Sortilin with Proximal Left Anterior Descending Artery Obstruction · 2026 · Related
  3. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials · Thomas A. Zelniker · 2018 · 2885 citations · Cited by this paper
  4. A Forgotten Prosthesis in a Forgotten Valve: A Surprising Case Report · 2024 · Related
  5. Colchicine in Patients with Chronic Coronary Disease · Stefan Mark Nidorf · 2020 · 2262 citations · Cited by this paper
  6. OCT Findings from a Spontaneously Recanalized Coronary Thrombus Treated with a Drug-Coated Balloon · 2026 · Related
  7. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association · Sharonne N. Hayes · 2018 · 1307 citations · Cited by this paper
  8. Risk Stratification of Postoperative Vasoplegia After Cardiac Surgery · 2026 · Related
  9. Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease · Stefan Mark Nidorf · 2012 · 1060 citations · Cited by this paper
  10. Schweizer Preis für Angiologie 2024 /Prix Suisse d’Angiologie 2024 · 2024 · Related
  11. SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials · Muthiah Vaduganathan · 2022 · 982 citations · Cited by this paper
  12. The Biaxillary Access: A Cadaveric Proof-of-Concept Study of a Minimally Invasive Strategy for Combined Coronary Artery Bypass Grafting and Valve Surgery · 2026 · Related
  13. Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women · Harmony R. Reynolds · 2020 · 326 citations · Cited by this paper
  14. Mechanisms Involved in the Adverse Cardiovascular Effects of Selective Cyclooxygenase-2 Inhibitors · 2025 · Related
  15. Empagliflozin in acute myocardial infarction: the EMMY trial · Dirk von Lewinski · 2022 · 308 citations · Cited by this paper
  16. Impact of New-Onset Atrial Fibrillation in Critically Ill Patients—A Retrospective Study · 2026 · Related
  17. Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure · Stefan Karl James · 2023 · 304 citations · Cited by this paper
  18. Post-operative Takotsubo Cardiomyopathy in Elective Mitral Valve Replacement · 2024 · Related
  19. Empagliflozin after Acute Myocardial Infarction · Javed Butler · 2024 · 298 citations · Cited by this paper
  20. A Promising New Beginning for Cardiovascular Medicine—The Journal for the Interdisciplinary Heart Team · 2026 · Related
  21. Characterization and outcomes of women and men with non–ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: Results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) Quality Improvement Initiative · Erika R. Gehrie · 2009 · 236 citations · Cited by this paper
  22. Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries · Alf Inge Larsen · 2005 · 180 citations · Cited by this paper
  23. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction · Nathan Mewton · 2021 · 179 citations · Cited by this paper
  24. Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry · Pasquale Paolisso · 2022 · 152 citations · Cited by this paper
  25. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review · Fan-shun Zhang · 2022 · 144 citations · Cited by this paper
  26. Myocardial infarction with non-obstructive coronary artery disease · Bertil Lindahl · 2021 · 116 citations · Cited by this paper
  27. Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role? · Asmaa Elrakaybi · 2022 · 115 citations · Cited by this paper
  28. Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration · Sivabaskari Pasupathy · 2021 · 114 citations · Cited by this paper
  29. Morbidity and cause‐specific mortality in first‐time myocardial infarction with nonobstructive coronary arteries · Kai M. Eggers · 2018 · 95 citations · Cited by this paper
  30. Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries · Rocco Montone Montone · 2022 · 80 citations · Cited by this paper
  31. Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis · Lars G. Hemkens · 2016 · 60 citations · Cited by this paper
  32. Dapagliflozin attenuates arrhythmic vulnerabilities by regulating connexin43 expression via the AMPK pathway in post-infarcted rat hearts · Cheng-Che Lee · 2021 · 55 citations · Cited by this paper
  33. Colchicine in ischemic heart disease: the good, the bad and the ugly · Domenico D’Amario · 2021 · 52 citations · Cited by this paper
  34. The Role of Cardiac Magnetic Resonance in Myocardial Infarction and Non-obstructive Coronary Arteries · Kate Liang · 2022 · 51 citations · Cited by this paper
  35. Colchicine and myocardial infarction: A review · Mariama Akodad · 2020 · 46 citations · Cited by this paper
  36. Sodium/glucose Co-Transporter 2 Inhibitor, Empagliflozin, Alleviated Transient Expression of SGLT2 after Myocardial Infarction · Soo Yong Lee · 2020 · 45 citations · Cited by this paper
  37. Attenuation of Adverse Postinfarction Left Ventricular Remodeling with Empagliflozin Enhances Mitochondria-Linked Cellular Energetics and Mitochondrial Biogenesis · Yang Song · 2021 · 45 citations · Cited by this paper
  38. Colchicine: an affordable anti-inflammatory agent for atherosclerosis · Peter L. Thompson · 2018 · 34 citations · Cited by this paper
  39. What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries · Robert Sykes · 2021 · 27 citations · Cited by this paper

Source: OpenAlex (CC0)